These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26571145)

  • 21. Antiplatelet therapy and the risk of ischemic and hemorrhagic complications associated with Pipeline embolization of cerebral aneurysms: a systematic review and pooled analysis.
    Saber H; Kherallah RY; Hadied MO; Kazemlou S; Chamiraju P; Narayanan S
    J Neurointerv Surg; 2019 Apr; 11(4):362-366. PubMed ID: 30201813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related outcomes following intracranial aneurysm treatment with the Pipeline Embolization Device: a subgroup analysis of the IntrePED registry.
    Brinjikji W; Kallmes DF; Cloft HJ; Lanzino G
    J Neurosurg; 2016 Jun; 124(6):1726-30. PubMed ID: 26544776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapy.
    Young CC; Bass DI; Cruz MJ; Carroll K; Vanent KN; Lee C; Sen RD; Feroze AH; Williams JR; Levy S; McCray D; Kelly CM; Barber J; Kim LJ; Levitt MR
    J Clin Neurosci; 2022 Nov; 105():66-72. PubMed ID: 36113244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy.
    Nishi H; Nakahara I; Matsumoto S; Hashimoto T; Ohta T; Sadamasa N; Ishibashi R; Gomi M; Saka M; Miyata H; Watanabe S; Okata T; Sonoda K; Kouge J; Ishii A; Nagata I; Kira J
    J Neurointerv Surg; 2016 Sep; 8(9):949-53. PubMed ID: 26297788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antiplatelet therapy and platelet function testing on hemorrhagic and thrombotic complications in patients with cerebral aneurysms treated with the pipeline embolization device: a review and meta-analysis.
    Skukalek SL; Winkler AM; Kang J; Dion JE; Cawley CM; Webb A; Dannenbaum MJ; Schuette AJ; Asbury B; Tong FC
    J Neurointerv Surg; 2016 Jan; 8(1):58-65. PubMed ID: 25385746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet Premedication for Stent-Assisted Coil Embolization of Intracranial Aneurysms: Low-Dose Prasugrel vs Clopidogrel.
    Choi HH; Lee JJ; Cho YD; Han MH; Cho WS; Kim JE; An SJ; Mun JH; Yoo DH; Kang HS
    Neurosurgery; 2018 Nov; 83(5):981-988. PubMed ID: 29301051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of antiplatelet therapy on thromboembolism after flow diversion with the pipeline embolization device.
    Heller RS; Dandamudi V; Lanfranchi M; Malek AM
    J Neurosurg; 2013 Dec; 119(6):1603-10. PubMed ID: 23971953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
    Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response.
    Kayan Y; Delgado Almandoz JE; Fease JL; Milner AM; Scholz JM; Mulder M
    J Neurointerv Surg; 2017 Aug; 9(8):792-796. PubMed ID: 27436404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pipeline Embolization Device for Small Intracranial Aneurysms: Evaluation of Safety and Efficacy in a Multicenter Cohort.
    Griessenauer CJ; Ogilvy CS; Foreman PM; Chua MH; Harrigan MR; He L; Fusco MR; Mocco JD; Stapleton CJ; Patel AB; Sonig A; Siddiqui AH; Thomas AJ
    Neurosurgery; 2017 Apr; 80(4):579-587. PubMed ID: 27489165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
    Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Hemorrhagic Complications following Pipeline Embolization Device Treatment of Intracranial Aneurysms: Results from the International Retrospective Study of the Pipeline Embolization Device.
    Brinjikji W; Lanzino G; Cloft HJ; Siddiqui AH; Kallmes DF
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2308-13. PubMed ID: 26251427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole blood aggregometry prior to Pipeline embolization device treatment of intracranial aneurysms: defining an optimal platelet inhibition cutoff value for clopidogrel.
    Foreman PM; Enriquez-Marulanda A; Mooney JH; Schmalz PGR; Griessenauer CJ; Deveikis JP; Harrigan MR
    J Neurosurg; 2019 Nov; 131(5):1437-1444. PubMed ID: 30497139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
    Nakagawa I; Park HS; Yokoyama S; Wada T; Hironaka Y; Motoyama Y; Takayama K; Kichikawa K; Nakase H
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):163-71. PubMed ID: 26493334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacy-Mediated Antiplatelet Management Protocol Compared to One-time Platelet Function Testing Prior to Pipeline Embolization of Cerebral Aneurysms: A Propensity Score-Matched Cohort Study.
    Griessenauer CJ; Jain A; Enriquez-Marulanda A; Gupta R; Adeeb N; Moore JM; Grassi SA; Dalal SS; Ogilvy CS; Thomas AJ; Schirmer CM
    Neurosurgery; 2019 Mar; 84(3):673-679. PubMed ID: 29608747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent use of the Pipeline Embolization Device and coils for intracranial aneurysms: technique, safety, and efficacy.
    Nossek E; Chalif DJ; Chakraborty S; Lombardo K; Black KS; Setton A
    J Neurosurg; 2015 Apr; 122(4):904-11. PubMed ID: 25658781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety of Pipeline flow diversion in fusiform vertebrobasilar aneurysms: a consecutive case series with longer-term follow-up from a single US center.
    Natarajan SK; Lin N; Sonig A; Rai AT; Carpenter JS; Levy EI; Siddiqui AH
    J Neurosurg; 2016 Jul; 125(1):111-9. PubMed ID: 26654175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-treatment rates after treatment with the Pipeline Embolization Device alone versus Pipeline and coil embolization of cerebral aneurysms: a single-center experience.
    Park MS; Nanaszko M; Sanborn MR; Moon K; Albuquerque FC; McDougall CG
    J Neurosurg; 2016 Jul; 125(1):137-44. PubMed ID: 26684772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolution of cranial neuropathies following treatment of intracranial aneurysms with the Pipeline Embolization Device.
    Moon K; Albuquerque FC; Ducruet AF; Crowley RW; McDougall CG
    J Neurosurg; 2014 Nov; 121(5):1085-92. PubMed ID: 25192477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.